Trial Profile
Effect of sitagliptin on vascular endothelial function in Type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2017
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Aug 2017 Status changed from not yet recruiting to completed.
- 11 Feb 2013 New trial record